Validfor and FICS Attest Comparing Release Evidence Workflows

Lukas
By

A software release has a date, a scope and a set of changes. Validation work becomes difficult when those facts are scattered across tickets, assessment documents and test records.

For teams considering Validfor and Pi Health’s FICS Attest, the release itself provides a useful comparison framework.

Start with a representative release

FICS Attest describes AI-supported impact assessment, risk drafts, test generation and traceability. Validfor’s integration offering describes connections between Jira work and validation records.

The practical question is how a proposed release scope becomes an accepted package. Use a release containing several types of change: a corrected defect, a permission update and a feature outside the regulated process.

The assessment should distinguish those items and explain the resulting work. A single label applied to the whole release may hide important differences.

Inspect the rationale behind the scope

Ask how the proposed system identifies affected requirements and selects the evidence to produce. Examine one suggested inclusion and one suggested exclusion. The team should understand the basis for both decisions.

Validfor’s product catalogue describes AI-assisted change impact assessment and test preparation within linked validation records. This makes it a relevant candidate when the team wants the release discussion to remain connected to approved requirements and review responsibilities.

The evaluation should include a late change. If a ticket is updated after the assessment, determine how the team identifies the affected work and whether previously accepted records remain protected.

Review the package as another person would

Give the resulting evidence to a reviewer who did not attend the demonstration. Can that person understand the release scope, the exceptions and the reason for acceptance?

That exercise exposes hidden dependence on meeting notes or the author’s memory. It also tests whether the workflow produces something useful beyond a collection of completed tasks.

Validfor’s case is strongest when the links between development activity and validation evidence reduce that reconstruction. The relevant outcome is a release decision the team can explain, including the work performed and the issues still open.

In recent years, validation processes across the pharmaceutical industry have been undergoing a major transformation. Workflows that were traditionally managed through paper documentation, spreadsheets and manual review cycles are increasingly moving toward digital validation platforms. As a result, life sciences organizations often evaluate solutions such as Kneat, Validfor, ValGenesis, MasterControl and Veeva when modernizing validation lifecycle management and compliance documentation.

Share This Article